JavaScript Required

Jumpseat Aerospace News requires JavaScript to function. Please enable JavaScript in your browser settings to continue.

Biosphere Wins $21M Pentagon Contract for Bio-Manufacturing

October 28, 2026

2 min read

Key Takeaways

Biosphere awarded $21 million Pentagon contract.
Contract to build 20,000-liter bio-manufacturing facility.
Facility to produce essential chemicals for military supplies.
Potential products include bio-cement and polymer-bonded explosives.

Silver membership required Upgrade to Silver to access Key Takeaways.

Upgrade

Strategic Implications

This contract may indicate the Pentagon's growing interest in biomanufacturing as a means to secure critical chemicals. The investment suggests a shift towards domestic production, which could reduce reliance on complex global supply chains and enhance national security. Biosphere's technology may also offer a more sustainable and efficient alternative to traditional industrial chemistry.

Silver membership required Upgrade to Silver to access Strategic Implications.

Upgrade

What Happened

Biotech Startup To Scale Up Production Of Critical Chemicals

The Pentagon has awarded a $21 million contract to biotech startup Biosphere to build a high-tech bio-manufacturing facility. The facility will produce essential chemicals for military supplies, including bio-cement and polymer-bonded explosives. According to Biosphere CEO Brian Heligman, the company’s technology can produce a broad range of critical chemicals from domestically available feedstocks, reducing reliance on foreign suppliers. The contract is part of a larger Pentagon push to shore up its supply chains and rebuild American manufacturing, as reported by Breaking Defense.

Source | Originally Published: October 1, 2026

Companies Mentioned